HAVCR2 and neoplasm: Inhibition of lipid oxidation with ranolazine in the TRAMPC1 mouse model resulted in decreased expression of the immune checkpoint block protein Tim3 in CD8+ cells, increased the content of macrophages in the tumor site, and decreased the number of immunosuppressive monocytes in the blood [107].